欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Metabolism > MSDC-0602

浏览历史

S88275

MSDC-0602

源叶(MedMol) ≥97%
  • 英文名:
  • 5-(4-(2-(3-METHOXYPHENYL)-2-OXOETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE
  • 别名:
  • CAS号:
  • 1133819-87-0
  • 分子式:
  • C19H17NO5S
  • 分子量:
  • 371.40698
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S88275-5mg ≥97% ¥302.00元 10 - - - EA 加入购物车
源叶(MedMol) S88275-10mg ≥97% ¥457.00元 8 - - - EA 加入购物车
源叶(MedMol) S88275-50mg ≥97% ¥1666.00元 3 - - - EA 加入购物车
源叶(MedMol) S88275-100mg ≥97% ¥2888.00元 3 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: Azemiglitazone (MSDC-0602) 是一种直接的线粒体丙酮酸载体 (mitochondrial pyruvate carrier, MPC) 抑制剂,可调节小鼠和人类的中央碳代谢
  • 靶点: MPC;MitochondrialMetabolism; mTOR
  • 体外研究:
    Azemiglitazone (MSDC-0602) is a modified hiazolidinediones (TZDP) with alterations in the carbon backbone that limit the ability to bind PPARγ, with the IC50 for PPARγ of 18.25 μM. Azemiglitazone (MSDC-0602) also shows the affinity for mitochondrial binding, with the IC50 of 1.38 μM. Using a Gal4-PPARγ construct containing the ligand binding domain of mouse PPARγ, MSDC-0602 only minimally activates Gal4-PPARγ in HepG2 cells even at a concentration of 50 μM.
  • 体内研究:
    Azemiglitazone (MSDC-0602) corrects plasma glucose, nonesterified fatty acids, triglycerides, cholesterol, and insulin concentrations, which are elevated in ob/ob mice compared with lean controls. Treatment with Azemiglitazone (MSDC-0602) also significantly improved glucose and insulin tolerance in ob/ob mice
  • 细胞实验: Cell lines: HepG2 hepatoma cells Concentrations: 0.5 nM, 5 nM, 50 nM, 0.5 μM, 5 μM and 50μM Incubation Time: 48 h Method: HepG2 hepatoma cells were co-transfected by calcium phosphate coprecipitation with expression vectors for Gal4-PPARγ (ligand binding domain only) or Gal4-PPARα, heterologous firefly luciferase reporter construct driven by five copies of a Gal4 response element, and SV40-driven renilla luciferase reporter construct. Transfected cells were treated with PPARγ agonists (rosiglitazone and pioglitazone), PPARα agonist (GW7647), or MSDC-0602 for 24 h. Cell lysate firefly and renilla luciferase activity was assessed 48 h later by using the Dual-Glo kit. Firefly luciferase activity was corrected for renilla luciferase activity, and DMSO (vehicle) values were normalized to 1.0.
  • 参考文献:
    1. ADAM J. RAUCKHORST, et al. Diabetes 2021 Jun; 70(Supplement 1) 2. Chen Z, et al. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione. J Biol Chem. 2012 Jul 6;287(28):23537-48.
  • 溶解性: DMSO  :  125  mg/mL  (336.56  mM;  Need  ultrasonic);H2O  :  <  0.1  mg/mL  (insoluble)
  • 保存条件: -20°C
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.692 ml 13.462 ml 26.925 ml
    5 mM 0.538 ml 2.692 ml 5.385 ml
    10 mM 0.269 ml 1.346 ml 2.692 ml
    50 mM 0.054 ml 0.269 ml 0.538 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。